tirzepatide increase blood pressure How Does Work? GLP-1 drugs tied to elevated

Retatrutide is an investigational triple receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors to address multiple aspects of metabolic dysfunction

Oral mucosal lesions are typically detected a decade later than labial lesions

Interestingly, biased agonism at the GLP-1R favoring cAMP generation over -arrestin recruitment could be involved in the efficacy of tirzepatide resulting in less receptor internalization

Growing evidence confirms that ferroptosis is associated with the development of atherosclerosis and can be an effective therapeutic target

A probiotic specifically designed for GLP-1 users addresses the gut microbiome changes that both Hashimoto's and GLP-1 medications create